Live feed17:00:00·334dPRReleasevia QuantisnowAmylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025ByQuantisnow·Wall Street's wire, on your screen.AMLX· Amylyx Pharmaceuticals Inc.Health Care
